This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Universal Health Realty Stock Declines Following Mixed Q2 Earnings
by Zacks Equity Research
UHT posts lower second-quarter 2025 earnings as higher borrowing costs and weaker property income weigh on results.
UHT Downgraded to Neutral Amid Leasing & Rate Pressures
by Zacks Equity Research
Universal Health Realty's lease stability and dividend yield support income, but muted leasing, variable-rate debt and tenant concentration weigh on growth prospects.
Universal Health Realty Stock Gains Despite Earnings and FFO Dip
by Zacks Equity Research
UHT reports lower first-quarter 2025 earnings and revenues as higher interest expenses and reduced property income weigh on results.
UHT Stock Gains Following Earnings Rise in Q4, FFO Improves Y/Y
by Zacks Equity Research
Universal Health Realty's net income and FFO increase in fourth-quarter 2024, driven by higher property income despite increased interest expenses.
Zacks Initiates Coverage of Universal Health Realty With Outperform Recommendation
by Debanjana Dey
Discover why Zacks rates Universal Health Realty as "Outperform", being the first on Wall Street to initiate coverage on the stock. Explore UHT's strategic expansions, financial health and operational efficiency.
The Zacks Analyst Blog Berkshire Hathaway, Exxon Mobil, Novo Nordisk and Universal Health Realty Income Trust
by Zacks Equity Research
Berkshire Hathaway, Exxon Mobil, Novo Nordisk and Universal Health Realty Income Trust are included in this Analyst Blog.